Page 17 - Heart Failure Clinical Guidelines

17

VIII. CHEMOTHERAPY INDUCED CARDIOMYOPATHY

A. Initial Evaluation for Patient with Chemotherapy Induced Cardiomyopathy

1. Additional Detailed History and Physical
Chemotherapy History (esp Doxyrubicin)
Cancer History (remission, treatment, likelihood of relapse)

2. Laboratories, Tests

MRI with contrast (evaluate function, fibrosis,)
Other Laboratories to Consider Based on History & Physical
1. Cardiomyopathy panel if had low exposure to chemotherapy

B. Long-Term Medical Management for Chemotherapy-Induced Cardiomyopathy

1. Follow Section I-B

C. Long-Term Follow-up Schedule for Chemotherapy Induced Cardiomyopathy

1. Follow Section I-C